Aldurazyme laronidase: Began Phase III trial

BioMarin Pharmaceutical Inc. (BMRN; SWX:BMRN), Novato, Calif. Product: Aldurazyme laronidase Business: Metabolic Therapeutic category: Metabolism, Enzyme replacement Target: Lysosomal carbohydrates ...